Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The regulatory effect and molecular mechanism of Epstein-Barr virus protein LMP-1 in SLE susceptibility gene expression. | Immunol Lett | 2025 | 40023262 | PubTator, text mining | PubMed |
| PD-L1/PD-L2 genetic profile in the molecular cytogenetic classification of classic Hodgkin lymphoma. | Virchows Arch | 2025 | 39976683 | PubTator, text mining | PubMed |
| Detection of the 30-bp deletion and protein expression of Epstein-Barr virus latent membrane protein 1 in extranodal NK/T cell lymphoma and its clinicopathological significance. | Diagn Pathol | 2025 | 39948602 | PubTator, text mining | PubMed |
| Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas. | Blood Adv | 2025 | 39908567 | PubTator, text mining | PubMed |
| Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications. | Med Oncol | 2025 | 39888474 | PubTator, text mining | PubMed |
| Small microplastics have much higher mass concentrations than large microplastics at the surface of nine major European rivers. | Environ Sci Pollut Res Int | 2025 | 39090295 | PubTator, text mining | PubMed |
| Simultaneous activation and blockade of autophagy to fight hepatocellular carcinoma. | Autophagy Rep | 2024 | 40395533 | PubTator, text mining | PubMed |
| Exploring the role of Epstein-Barr virus infection on the clinical features and survival in locally advanced cervical cancer: a retrospective cohort study. | Front Oncol | 2024 | 39777354 | PubTator, text mining | PubMed |
| Celebrating a year of immunotherapy/cell and gene therapy in Blood Advances. | Blood Adv | 2024 | 39718780 | PubTator, text mining | PubMed |
| In Silico Modeling and Characterization of Epstein-Barr Virus Latent Membrane Protein 1 Protein. | ACS Omega | 2024 | 39713625 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Photodynamic Therapy 2.0. | Biomedicines | 2024 | 39594992 | PubTator, text mining | PubMed |
| Unveiling the promise: Exosomes as game-changers in anti-infective therapy. | Exploration (Beijing) | 2024 | 39439498 | PubTator, text mining | PubMed |
| Targeting the LMP1-ALIX axis in EBV+ nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity. | Cancer Commun (Lond) | 2024 | 39402748 | PubTator, text mining | PubMed |
| Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in spontaneous lymphoblastoid cell lines. | PLoS Pathog | 2024 | 39325843 | PubTator, text mining | PubMed |
| The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program. | PLoS Pathog | 2024 | 39241017 | PubTator, text mining | PubMed |
| Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity. | Signal Transduct Target Ther | 2024 | 39174522 | PubTator, text mining | PubMed |
| Evodiamine suppresses endometriosis development induced by early EBV exposure through inhibition of ERβ. | Front Pharmacol | 2024 | 39148548 | PubTator, text mining | PubMed |
| Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway. | Proc Natl Acad Sci U S A | 2024 | 39141346 | PubTator, text mining | PubMed |
| Evaluating AI Proficiency in Nuclear Cardiology: Large Language Models take on the Board Preparation Exam. | medRxiv | 2024 | 39072028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=7